Hope this wasn't posted yet. I haven't had much time to follow the forum and don't see it in recent topics ...
16 Apr 2015
Two years after they first ran against a wall trying to get amyloid scans reimbursed by insurance, researchers now have their chance to prove the costly procedure is worth it. The Centers for Medicare & Medicaid Services (CMS) has approved the protocol for a four-year, $100 million study called Imaging Dementia—Evidence for Amyloid Scanning. IDEAS was spearheaded by Maria Carrillo of the Alzheimer’s Association and will be managed by the American College of Radiology (ACR) in Reston, Virginia. This massive study aims to examine how well amyloid imaging performs in clinics outside the small, rarefied world of clinical trials and tertiary academic care. IDEAS will measure whether getting a scan can affect the diagnosis, management, and future healthcare of people whose cognitive symptoms cannot be definitively attributed to a cause by clinical diagnosis alone. “More knowledge about clinical use of amyloid imaging is important not only for accurate diagnosis of Alzheimer’s, but also for the potential future use of a therapeutic agent,” Carrillo told Alzforum.
http://www.alzforum.org/news/community- ... l-practice